Inixi Bio, Inc

Inixi Bio, Inc is a privately held biotechnology firm focused on developing innovative solutions using synthetic biology to tackle health and sustainability challenges in various sectors. Founded in 2024 in Missouri, US, Inixi Bio, Inc specializes in biotechnology solutions that utilize synthetic biology. The company has engaged in 1 deal, with their most recent funding round occurring on May 23, 2025. The founder's history includes prior ventures, although specific details are not disclosed.

Inixi Bio specializes in advanced biotechnology solutions leveraging synthetic biology to address health and sustainability challenges. Their core offerings include biomanufacturing platforms that produce sustainable bio-based materials and therapeutics through engineered microorganisms, catering to sectors such as healthcare and industrial manufacturing. Inixi Bio generates revenue through B2B transactions with pharmaceutical and industrial clients, focusing on customized biomanufacturing solutions. Their revenue streams include licensing agreements and direct sales, with pricing structures tailored to meet market needs, ensuring competitive positioning in the biotechnology sector.

In May 2025, Inixi Bio, Inc raised an undisclosed amount of Seed funding from new investor SOSV, which will support their initiatives for developing new products and expanding into new markets. The company aims to enhance their product line and target specific markets for growth in the coming years.